Regulatory Daily Summary
Regulatory Daily Summary: What Happened on October 20, 2026
MFN deadline passes for mid-sized drugmakers
Companies without agreements could face tariffs on imported goods.
Today in brief
Mid-sized drugmakers missed the deadline to reach Most-Favored Nation agreements with the administration, leaving non-signatories potentially exposed to tariffs on imported goods.1
Also worth knowing
-
P
The initiative aims to lower U.S. drug prices and encourage domestic manufacturing.1